The Evidence Gap: Immunotherapy Timing in Early-Stage NSCLC?January 6, 2025Lung CancerPatient & Survivor CareImmunotherapyImmuno-oncology
Intratumoral Dendritic Cell Therapy Shows Promise in Early-Stage ERBB2-Positive Breast CancerDecember 9, 2024Breast CancerImmuno-oncologyImmunotherapyPatient & Survivor Care
FDA Approves Durvalumab for Limited-Stage SCLCDecember 6, 2024Lung CancerImmunotherapyPatient & Survivor CarePractice Management
New Cancer Vaccines on the Horizon: Renewed Hope or Hype?December 6, 2024Preventive CarePatient & Survivor CareImmunotherapyImmuno-oncologyMixed TopicsGynecologic CancerGenitourinary Cancer
Cancer Mortality Not Higher for Patients With Autoimmune Disease on Checkpoint InhibitorsNovember 21, 2024ImmunotherapyGastroenterology
Outpatient CAR T: Safe, Effective, AccessibleNovember 4, 2024Immuno-oncologyImmunotherapyLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMixed TopicsPractice ManagementPatient & Survivor Care
Many Hurdles Exist to Treating Lung Cancer With CAR T CellsOctober 10, 2024Lung CancerImmunotherapyImmuno-oncologyPatient & Survivor CarePractice Management
How to Treat Cancer While Preserving FertilityOctober 9, 2024Patient & Survivor CareImmunotherapyBreast CancerPreventive CareMixed TopicsGynecologic CancerGenitourinary Cancer
FDA Panel Votes for Limits on Gastric, Esophageal Cancer ImmunotherapySeptember 30, 2024Gastrointestinal CancerGastroenterologyPractice ManagementImmunotherapyPatient & Survivor Care
Melanoma: Neoadjuvant Immunotherapy Provides Optimal Survival ResultsSeptember 23, 2024MelanomaImmunotherapy
Cancer Treatment 101: A Primer for Non-OncologistsAugust 23, 2024Breast CancerCNS/Brain CancerDLBCLFollicular LymphomaGastroenterologyGastrointestinal CancerImmunotherapy
Diagnosing, Treating Rashes In Patients on Immune Checkpoint InhibitorsAugust 21, 2024MelanomaMixed TopicsImmunotherapyImmuno-oncology
Jeffrey Weber, MD, PhD, Giant of Cancer Care, DiesAugust 21, 2024Mixed TopicsMelanomaImmunotherapyImmuno-oncologyPractice Management
Few Severe Toxicities After SBRT in Oligometastatic CancerAugust 20, 2024Breast CancerLung CancerGastrointestinal CancerGenitourinary CancerImmunotherapy
